Financial Instruments

12 Months Ended

Dec. 31, 2013

Investments, All Other Investments [Abstract]

Financial Instruments Disclosure [Text Block]

14. Financial Instruments

The following table sets forth the financial instruments as of December 31, 2013 and 2012, that the Company measured at fair value, on a recurring basis by level, within the fair value hierarchy (in thousands). As required by the standard, assets measured at fair value are classified in their entirety based on the lowest level of input that is significant to their fair value measurement.

December 31, 2013	Level 1		Level 2		Level 3

Liability
Derivatives	$	—	$	577	$	—


December 31, 2012	Level 1		Level 2		Level 3

Assets
Derivatives	$	—	$	125	$	—

The Level 2 assets contain foreign currency forward contracts. Fair value is determined based on the observable market transactions of spot and forward rates. The fair value of these contracts as of December 31, 2013 is included in accrued expenses and fair value as of December 31, 2012 is included in prepaid expenses and other current assets in the accompanying consolidated balance sheets.

The Synodex subsidiary of the IADS segment has not achieved significant revenue to date and has incurred losses since inception. As a result in the third quarter of 2013, the Company evaluated the carrying value of the fixed assets of its Synodex subsidiary compared to its fair value and concluded that that the carrying value exceeds its fair value. This resulted in an impairment charge of $5.5 million for the year ended December 31, 2013. The fixed assets were measured at fair value on a nonrecurring basis using significant unobservable inputs (Level 3).